Bill Title: Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression to a patient when one or more of the following conditions are present: (1) the prescription dosage for the patient is 90 or more morphine milligram equivalents of an opioid medication per day; (2) an opioid medication is prescribed concurrently with a prescription for benzodiazepine; (3) the patient presents with an increased risk for overdose, including a patient with a history of overdose, a patient with a history of substance use disorder, or a patient at risk for returning to a high dose of opioid medication to which the patient is no longer tolerant. Provides other requirements and exemptions. Makes other changes. Effective January 1, 2020.

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Introduced - Dead) 2019-03-29 - House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee [HB2638 Detail]

Text: Latest bill text (Introduced) [HTML]

---

Sponsors

Name	Type	Sponsorship	District	Financial	Encyclopedia	Biography
Representative Marcus Evans [D]	Primary	Sponsored Bills	HD-033	FollowTheMoney	Ballotpedia	VoteSmart
Representative Robyn Gabel [D]	Cosponsor	Sponsored Bills	HD-018	FollowTheMoney	Ballotpedia	VoteSmart
Representative Katie Stuart [D]	Cosponsor	Sponsored Bills	HD-112	FollowTheMoney	Ballotpedia	VoteSmart
Representative Michelle Mussman [D]	Cosponsor	Sponsored Bills	HD-056	FollowTheMoney	Ballotpedia	VoteSmart

Social Comments on IL HB2638